Datascan Pharmacy Software

Datascan Pharmacy SoftwareDatascan Pharmacy Software
Datascan Pharmacy Software

Datascan Pharmacy Software

Family-owned pharmacy management software provider for independent pharmacies since 1981.

DR 281981Active14Bohemia, United States
Rate

About

Datascan Pharmacy Software offers comprehensive pharmacy management solutions, including dispensing software and a point-of-sale system, designed for independent and retail pharmacies. Since 1981, they have provided software to help pharmacies increase profits, efficiency, and patient retention. Their product suite also includes mobile applications for patients and delivery, as well as specialized modules for compounding, doctor portals, and central store management.
Frequently asked

What does Datascan Pharmacy Software do?

Datascan Pharmacy Software offers comprehensive pharmacy management solutions, including dispensing software and a point-of-sale system, designed for independent and retail pharmacies. Since 1981, they have provided software to help pharmacies increase profits, efficiency, and patient retention. Their product suite also includes mobile applications for patients and delivery, as well as specialized modules for compounding, doctor portals, and central store management.

What is Datascan Pharmacy Software's revenue?

StartupHub estimates Datascan Pharmacy Software's annual revenue at $1.8M (range $1.1M to $3.1M, 69% confidence), based on comparable companies in the sector.

Where is Datascan Pharmacy Software headquartered?

Datascan Pharmacy Software is headquartered in Bohemia, United States.

When was Datascan Pharmacy Software founded?

Datascan Pharmacy Software was founded in 1981.

What industry does Datascan Pharmacy Software operate in?

Datascan Pharmacy Software operates in Vertical SaaS, HealthTech, RetailTech, Pharmacy Management Software.

How many employees does Datascan Pharmacy Software have?

Datascan Pharmacy Software has approximately 14 people on record.

HEADCOUNT
14
DOMAIN RATING
28
Comments

No comments yet. Be the first to share your take.